How long should prasugrel be held before a colonoscopy?

Prasugrel Management Before Colonoscopy

Hold prasugrel for 7 days before colonoscopy if polypectomy or other high-risk intervention is planned. 1

Risk Stratification Framework

The decision to hold prasugrel depends on whether the colonoscopy is classified as low-risk or high-risk:

Low-Risk Procedures

• Diagnostic colonoscopy with biopsies only
• No need to hold prasugrel 1

High-Risk Procedures

• Polypectomy (polyp removal)
• Endoscopic mucosal resection (EMR)
• Endoscopic submucosal dissection (ESD)
• Any therapeutic intervention
• Hold prasugrel for 7 days 1

Patient Thrombotic Risk Assessment

Low Thrombotic Risk Patients

• Stop prasugrel 7 days before high-risk colonoscopy 1
• If on dual antiplatelet therapy (DAPT), continue aspirin throughout the periprocedural period 1
• Resume prasugrel 1-2 days after the procedure depending on bleeding risk 1

High Thrombotic Risk Patients

These include patients with:

• Recent coronary stent (≤6-12 months for drug-eluting stents, ≤1 month for bare metal stents) 1
• Recent acute coronary syndrome
• Ischemic heart disease without stent
• Cerebrovascular disease
• Peripheral vascular disease

For high-risk patients: Consult with the interventional cardiologist before stopping prasugrel 1. The cardiologist must weigh the risk of stent thrombosis against procedural bleeding risk. Continue aspirin in all cases. 1

Pharmacologic Rationale

The 7-day holding period is based on prasugrel's pharmacodynamics. Platelet aggregation gradually returns to baseline over 5-9 days after discontinuation, reflecting new platelet production rather than drug clearance. 2 The active metabolite has an elimination half-life of approximately 7 hours (range 2-15 hours), but the antiplatelet effect persists much longer due to irreversible platelet inhibition. 2

Critical Safety Considerations

Common Pitfalls to Avoid:

• Never stop prasugrel without consulting the prescribing cardiologist first, particularly in patients with recent stents, as premature discontinuation significantly increases risk of stent thrombosis, myocardial infarction, and death 2
• Do not confuse prasugrel with clopidogrel—both require 7 days of discontinuation, but prasugrel produces more potent platelet inhibition 1
• The FDA label explicitly states patients should inform physicians before any invasive procedure and that the performing physician should contact the prescribing provider before stopping prasugrel 2

Post-Procedure Management:

• Resume prasugrel 1-2 days after colonoscopy if no significant bleeding occurred 1
• Patients should be counseled about increased post-procedure hemorrhage risk compared to those not on antiplatelet agents 1
• If major bleeding occurs, prasugrel may need permanent discontinuation with cardiology consultation 1

Special Populations

For patients ≥75 years old or body weight <60 kg who are on reduced-dose prasugrel (5 mg daily), the same 7-day holding period applies before high-risk procedures. 1